Session Name: Pancreas and Islet: All Topics II
Session Type: Oral Abstract Session
Date: Saturday, May 30, 2020
Session Time: 3:15pm-4:45pm
Presentation Time: 3:39pm-3:51pm
*Purpose: Approximately 1/3 of pancreas transplant fail to gain glycemic control in the first days/weeks posttransplantation, requiring exogenous insulin administration. Delayed endocrine pancreas graft function (DPGF) usually resolves but may be associated with some decrease in graft survival.
*Methods: Endocrine islets were studied with light microscopy, immunostains for insulin, glucagon, CD3, CD20,CD68 and C4d and electron microscopy (EM) in 3 patients with protracted DPGF. Findings were compared with 3 control biopsies from patiensts with optimal graft function. On EM, insulin secretory granules per µm2 of β cell surface was quantitated in all biopsies (ImageJ software). The patients were induced with Alentuzumab (n=5) and Thymoglobulin (n=1) and received triple standard immunosuppression (IS).
*Results: In contrast to controls, marked injury of β cells was noted in DPGF with preservation of α cell morphology. Electron micrograph shows β cell with cytoplasmic vacuolization and sparse Insulin secretory granules, in contrast to normal density of glucagon secretory granules in the α cell.
Severe, statistically significant loss of insulin secretory granules was uniformly observed in DPGF. See table below.
After modification-adjustment of the IS regimen, 2 patients recovered graft function (totally and partially, respectively) and the other patient was re-listed due to primary non-function.
*Conclusions: Quantifiable loss of insulin secretory granules was observed in 3 patients with DPGF. In the absence of rejection or inflammatory changes suggesting allo- or autoimmune damage, these findings point to possible metabolic/toxic mechanisms for DPGF. Better understanding of this poorly characterized entity is necessary.
To cite this abstract in AMA style:Drachenberg CB, Papadimitriou JC, Scalea JR, Haririan A, Ugarte R, Niederhaus S, Bromberg J. Quantifiable Loss of Insulin Secretory Granules in Delayed Endocrine Pancreas Graft Function in Comparison to Controls [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/quantifiable-loss-of-insulin-secretory-granules-in-delayed-endocrine-pancreas-graft-function-in-comparison-to-controls/. Accessed August 10, 2022.
« Back to 2020 American Transplant Congress